A recent video compilation circulating online has put an uncomfortable spotlight on Luka Doncic and his defensive skills, and ...

Woman suing Taylor Swift gets bad news from Aileen Cannon Football fans triggered by ESPN’s flag yellow transition graphic ...

Funny beagles compilation packed with laughter and joy. Trump's Kennedy post after Tatiana Schlossberg death sparks anger US ...

The fiscal 2026 budget compiled by the administration of Prime Minister Sanae Takaichi includes debt-servicing expenses, such ...

Anthropology Rock What began as a cheeky joke quickly became one of 2025’s most talked-about internet moments. Creator Phoebe ...

From messy mealtime disasters and chaotic playtime mishaps to perfectly timed parenting blunders, this compilation captures ...

Oracle (ORCL) is rated 'Buy' due to a major valuation dislocation versus its $523B RPO backlog, despite recent CapEx-driven ...

Rick Warren is a Senior Features Editor from the United States. He is a lifelong gamer and comics fan who loves writing about everything in nerd culture, and absolutely adores Trophy hunting on PSN.

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 ...

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer’s ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...